View in EDS HTML Full Text PDF Full Text

Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis.

Saved in:
Bibliographic Details
Title: Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis.
Authors: Heseltine J; The Clatterbridge Cancer Centre, Clatterbridge Road, Bebington, Liverpool, CH63 4JY, UK. J.heseltine@nhs.net.; The University of Liverpool, Liverpool, UK. J.heseltine@nhs.net., Allison J; The Christie, Manchester, UK., Wong S; The Royal Marsden, London, UK., Prasad K; East Lancashire Teaching Hospitals, Lancashire, UK., Oong ZC; East Lancashire Teaching Hospitals, Lancashire, UK., Wong H; The Clatterbridge Cancer Centre, Clatterbridge Road, Bebington, Liverpool, CH63 4JY, UK., Law A; The Clatterbridge Cancer Centre, Clatterbridge Road, Bebington, Liverpool, CH63 4JY, UK., Charnley N; East Lancashire Teaching Hospitals, Lancashire, UK., Parikh O; East Lancashire Teaching Hospitals, Lancashire, UK., Waddell T; The Christie, Manchester, UK., Chow S; The Clatterbridge Cancer Centre, Clatterbridge Road, Bebington, Liverpool, CH63 4JY, UK.
Source: Targeted oncology [Target Oncol] 2023 Jul; Vol. 18 (4), pp. 593-599. Date of Electronic Publication: 2023 Jun 07.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37285073
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Heseltine+J%22">Heseltine J</searchLink>; The Clatterbridge Cancer Centre, Clatterbridge Road, Bebington, Liverpool, CH63 4JY, UK. J.heseltine@nhs.net.; The University of Liverpool, Liverpool, UK. J.heseltine@nhs.net.<br /><searchLink fieldCode="AU" term="%22Allison+J%22">Allison J</searchLink>; The Christie, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Wong+S%22">Wong S</searchLink>; The Royal Marsden, London, UK.<br /><searchLink fieldCode="AU" term="%22Prasad+K%22">Prasad K</searchLink>; East Lancashire Teaching Hospitals, Lancashire, UK.<br /><searchLink fieldCode="AU" term="%22Oong+ZC%22">Oong ZC</searchLink>; East Lancashire Teaching Hospitals, Lancashire, UK.<br /><searchLink fieldCode="AU" term="%22Wong+H%22">Wong H</searchLink>; The Clatterbridge Cancer Centre, Clatterbridge Road, Bebington, Liverpool, CH63 4JY, UK.<br /><searchLink fieldCode="AU" term="%22Law+A%22">Law A</searchLink>; The Clatterbridge Cancer Centre, Clatterbridge Road, Bebington, Liverpool, CH63 4JY, UK.<br /><searchLink fieldCode="AU" term="%22Charnley+N%22">Charnley N</searchLink>; East Lancashire Teaching Hospitals, Lancashire, UK.<br /><searchLink fieldCode="AU" term="%22Parikh+O%22">Parikh O</searchLink>; East Lancashire Teaching Hospitals, Lancashire, UK.<br /><searchLink fieldCode="AU" term="%22Waddell+T%22">Waddell T</searchLink>; The Christie, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Chow+S%22">Chow S</searchLink>; The Clatterbridge Cancer Centre, Clatterbridge Road, Bebington, Liverpool, CH63 4JY, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101270595%22">Targeted oncology</searchLink> [Target Oncol] 2023 Jul; Vol. 18 (4), pp. 593-599. <i>Date of Electronic Publication: </i>2023 Jun 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+France%22">Springer-Verlag France </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>101270595 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1776-260X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217762596%22">17762596 </searchLink><i>NLM ISO Abbreviation: </i>Target Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37285073
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11523-023-00972-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 593
    Titles:
      – TitleFull: Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Heseltine J
      – PersonEntity:
          Name:
            NameFull: Allison J
      – PersonEntity:
          Name:
            NameFull: Wong S
      – PersonEntity:
          Name:
            NameFull: Prasad K
      – PersonEntity:
          Name:
            NameFull: Oong ZC
      – PersonEntity:
          Name:
            NameFull: Wong H
      – PersonEntity:
          Name:
            NameFull: Law A
      – PersonEntity:
          Name:
            NameFull: Charnley N
      – PersonEntity:
          Name:
            NameFull: Parikh O
      – PersonEntity:
          Name:
            NameFull: Waddell T
      – PersonEntity:
          Name:
            NameFull: Chow S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2023 Jul
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1776-260X
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Targeted oncology
              Type: main
ResultId 1